AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)
AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)

Balance Sheet ACOR Quote Acorda Ther

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 159 307 294
ShortTermInvest 0 0 152
Cash 159 307 446
AccountReceivab 52 81 23
Inventories 43 38 29
DeferredIncomeT 4 0 0
OtherCurrentAss 6 2 11
TotalCurrentAss 273 442 528
PPE 74 87 117
AccumulatedDepr -40 -50 -57
NetPPE 34 37 61
EquityAndOtherI 0 0 0
Goodwill 281 287 282
IntangibleAsset 742 431 429
OtherLTAssets 8 2 0
TotalNonCurrent 1,070 756 772
TotalAssets 1,342 1,198 1,300
ShortTermDebt 1 0 0
AccountsPayable 30 31 49
TaxesPayable 0 0 0
AccruedLiabilit 84 84 55
DeferredRevenue 9 9 0
OtherCurrentLia 24 20 36
TotalCurrentLia 148 144 140
Debt 299 309 319
DeferredTaxesLi 93 22 7
DeferredRevenue 32 23 0
OtherLTLiabilit 106 179 221
TotalNonCurrent 530 534 547
TotalLiabilitie 678 678 688
CommonStock 0 0 0
AdditionalPaidI 921 969 1,005
RetainedEarning -244 -455 -394
AccumulatedOthe -13 7 3
TotalStockholde 664 520 612
TotalLiabilitie 1,342 1,198 1,300
Acorda Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Acorda Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.